Hong Kong vs North Macedonia: HIV-positive TB patients on ART (antiretroviral therapy)
Hong Kong
100.0%
in 2024
North Macedonia
100.0%
in 2020
Hong Kong rank
1st
North Macedonia rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Hong Kong
- North Macedonia
How they compare
Hong Kong currently reports 100.0% against 100.0% in North Macedonia, a difference of 0.0%.
Across all 5 years both countries report, North Macedonia has been ahead every year.
Hong Kong ranks 1st and North Macedonia ranks 1st of 144 countries.
North Macedonia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Hong Kong | North Macedonia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 43.5% | 100.0% | 56.5% | North Macedonia |
| 2010s | 37.0% | 100.0% | 63.0% | North Macedonia |
| 2020s | 89.0% | 100.0% | 11.0% | North Macedonia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Hong Kong or North Macedonia?
- Hong Kong, at 100.0% against 100.0% in North Macedonia as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Hong Kong and North Macedonia?
- 0.0%, with Hong Kong ahead.
- How many years of comparable data are there for Hong Kong and North Macedonia?
- 5 years are reported by both, from 2005 to 2020.
- How do Hong Kong and North Macedonia rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Hong Kong ranks 1st and North Macedonia ranks 1st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.